WallStreetZenWallStreetZen

NASDAQ: LQDA
Liquidia Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for LQDA

Based on 7 analysts offering 12 month price targets for Liquidia Corp

Min Forecast
$33.00-22.63%
Avg Forecast
$61.43+44.03%
Max Forecast
$92.00+115.71%

Should I buy or sell LQDA stock?

Based on 7 analysts offering ratings for Liquidia Corp.

Buy
Strong Buy
1 analysts 14.29%
Buy
4 analysts 57.14%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LQDA's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates LQDA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their LQDA stock forecasts and price targets.

LQDA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-10-15
lockedlocked$00.00+00.00%2026-10-14
lockedlocked$00.00+00.00%2026-10-14
lockedlocked$00.00+00.00%2026-10-14
lockedlocked$00.00+00.00%2026-10-14
Raymond James
Top 11%
90
BuyDowngrades$53.00+24.27%2026-10-01
Bank of America
Top 14%
87
HoldMaintains$92.00+115.71%2026-08-13

1 of 1

Forecast return on equity

Is LQDA forecast to generate an efficient return?

Company
314.07%
Industry
153.48%
Market
179.39%
LQDA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LQDA forecast to generate an efficient return on assets?

Company
117.41%
Industry
22.33%
LQDA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LQDA earnings per share forecast

What is LQDA's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$2.30+46.5%
Avg 2 year Forecast
$1.75+11.34%
Avg 3 year Forecast
$2.89+84.26%
LQDA's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

LQDA revenue forecast

What is LQDA's revenue in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$731.3M+62.19%
Avg 2 year Forecast
$678.9M+50.56%
Avg 3 year Forecast
$841.5M+86.62%
LQDA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LQDA earnings growth forecast

How is LQDA forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
17.52%
Industry
15.92%
Market
32.74%
LQDA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
LQDA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
LQDA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

LQDA revenue growth forecast

How is LQDA forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
23.12%
Industry
8.4%
Market
13.16%
LQDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LQDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LQDA vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
LQDA$42.65$61.43+44.03%Buy
RGC$7.67N/AN/A
INDV$34.47$43.00+24.75%Strong Buy
HCM$14.36$15.50+7.94%Buy
BHC$6.44$9.00+39.75%Hold
View Top Pharmaceutical Stocks

Liquidia Stock Forecast FAQ

Is Liquidia Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: LQDA) stock is to Buy LQDA stock.

Out of 7 analysts, 1 (14.29%) are recommending LQDA as a Strong Buy, 4 (57.14%) are recommending LQDA as a Buy, 2 (28.57%) are recommending LQDA as a Hold, 0 (0%) are recommending LQDA as a Sell, and 0 (0%) are recommending LQDA as a Strong Sell.

If you're new to stock investing, here's how to buy Liquidia stock.

What is LQDA's earnings growth forecast for 2026-2028?

(NASDAQ: LQDA) Liquidia's forecast annual earnings growth rate of 17.52% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 15.92%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.74%.

Liquidia's earnings in 2026 is $138,606,000.On average, 11 Wall Street analysts forecast LQDA's earnings for 2026 to be $205,879,400, with the lowest LQDA earnings forecast at $129,206,084, and the highest LQDA earnings forecast at $290,599,566. On average, 10 Wall Street analysts forecast LQDA's earnings for 2027 to be $156,461,541, with the lowest LQDA earnings forecast at $83,332,778, and the highest LQDA earnings forecast at $375,937,342.

In 2028, LQDA is forecast to generate $258,940,271 in earnings, with the lowest earnings forecast at $194,914,561 and the highest earnings forecast at $421,989,667.

What is LQDA's revenue growth forecast for 2026-2028?

(NASDAQ: LQDA) Liquidia's forecast annual revenue growth rate of 23.12% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.4%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.16%.

Liquidia's revenue in 2026 is $450,907,000.On average, 10 Wall Street analysts forecast LQDA's revenue for 2026 to be $65,461,432,344, with the lowest LQDA revenue forecast at $48,388,506,475, and the highest LQDA revenue forecast at $74,665,631,605. On average, 10 Wall Street analysts forecast LQDA's revenue for 2027 to be $60,766,691,011, with the lowest LQDA revenue forecast at $44,863,646,347, and the highest LQDA revenue forecast at $87,698,126,135.

In 2028, LQDA is forecast to generate $75,320,836,688 in revenue, with the lowest revenue forecast at $63,152,102,956 and the highest revenue forecast at $90,135,453,237.

What is LQDA's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: LQDA) forecast ROA is 117.41%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 22.33%.

What is LQDA's Price Target?

According to 7 Wall Street analysts that have issued a 1 year LQDA price target, the average LQDA price target is $61.43, with the highest LQDA stock price forecast at $92.00 and the lowest LQDA stock price forecast at $33.00.

On average, Wall Street analysts predict that Liquidia's share price could reach $61.43 by Oct 15, 2027. The average Liquidia stock price prediction forecasts a potential upside of 44.03% from the current LQDA share price of $42.65.

What is LQDA's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: LQDA) Liquidia's current Earnings Per Share (EPS) is $1.57. On average, analysts forecast that LQDA's EPS will be $2.30 for 2026, with the lowest EPS forecast at $1.44, and the highest EPS forecast at $3.25. On average, analysts forecast that LQDA's EPS will be $1.75 for 2027, with the lowest EPS forecast at $0.93, and the highest EPS forecast at $4.20. In 2028, LQDA's EPS is forecast to hit $2.89 (min: $2.18, max: $4.71).

What is LQDA's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: LQDA) forecast ROE is 314.07%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.